Clinical Trial Details
— Status: Terminated
Administrative data
NCT number |
NCT02892682 |
Other study ID # |
UF 9650 |
Secondary ID |
|
Status |
Terminated |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 31, 2016 |
Est. completion date |
May 10, 2023 |
Study information
Verified date |
November 2023 |
Source |
University Hospital, Montpellier |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Previous studies reported infraclinical modifications of the homeostasis in chronic
urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to
compare groups with isolated wheals, isolated angioedema, combination of both and hereditary
angioedema in terms of coagulation pathways.
Description:
Previous studies reported infraclinical modifications of the homeostasis in chronic
urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to
compare groups with isolated wheals, isolated angioedema, combination of both and hereditary
angioedema in terms of coagulation pathways. the main objective is to highlight a difference
between the rates of different coagulation factors in the 3 groups presenting different
categories of angiodemes patients with a group of patients with isolated superficial chronic
urticaria